1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Epilepsy Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Generation Type
6.1 First Generation Drugs
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Phenytoin
6.1.2.2 Carbamazepine
6.1.2.3 Oxcarbazepine
6.1.2.4 Valproate
6.1.2.5 Ethosuximide
6.1.2.6 Primidone
6.1.2.7 Phenobarbital
6.1.3 Market Forecast
6.2 Second Generation Drugs
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Levetiracetam
6.2.2.2 Lamotrigine
6.2.2.3 Topiramate
6.2.2.4 Pregabalin
6.2.2.5 Rufinamide
6.2.2.6 Zonisamide
6.2.3 Market Forecast
6.3 Third Generation Drugs
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Lacosamide
6.3.2.2 Perampanel
6.3.2.3 Eslicarbazepine Acetate
6.3.2.4 Ezogabine/Retigabine
6.3.3 Market Forecast
7 Market Breakup by Anti-Epileptics Drugs Type
7.1 Narrow-Spectrum AEDs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Broad-Spectrum AEDs
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmacy Stores
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alkem Laboratories Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Eisai Co. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 GSK plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 H. Lundbeck A/S
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Jazz Pharmaceuticals plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sunovion Pharmaceuticals Inc. (Sumitomo Dainippon Pharma Co. Ltd.)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 UCB S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
List of Figures
Figure 1: Global: Epilepsy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Epilepsy Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Epilepsy Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Epilepsy Drugs Market: Breakup by Generation Type (in %), 2024
Figure 5: Global: Epilepsy Drugs Market: Breakup by Anti-Epileptics Drugs Type (in %), 2024
Figure 6: Global: Epilepsy Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Epilepsy Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Epilepsy Drugs (First Generation Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Epilepsy Drugs (First Generation Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Epilepsy Drugs (Second Generation Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Epilepsy Drugs (Second Generation Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Epilepsy Drugs (Third Generation Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Epilepsy Drugs (Third Generation Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Epilepsy Drugs (Narrow-Spectrum AEDs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Epilepsy Drugs (Narrow-Spectrum AEDs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Epilepsy Drugs (Broad-Spectrum AEDs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Epilepsy Drugs (Broad-Spectrum AEDs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Epilepsy Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Epilepsy Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Epilepsy Drugs (Pharmacy Stores) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Epilepsy Drugs (Pharmacy Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Epilepsy Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Epilepsy Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: North America: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: North America: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: United States: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: United States: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Canada: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Canada: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Asia-Pacific: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Asia-Pacific: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: China: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: China: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Japan: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Japan: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: India: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: India: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: South Korea: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: South Korea: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Australia: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Australia: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Indonesia: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Indonesia: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Others: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Others: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Europe: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Europe: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Germany: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Germany: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: France: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: France: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: United Kingdom: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: United Kingdom: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Italy: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Italy: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Spain: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Spain: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Russia: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Russia: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Others: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Others: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Latin America: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Latin America: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Brazil: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Brazil: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Mexico: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Mexico: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Middle East and Africa: Epilepsy Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Middle East and Africa: Epilepsy Drugs Market: Breakup by Country (in %), 2024
Figure 72: Middle East and Africa: Epilepsy Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Global: Epilepsy Drugs Industry: Drivers, Restraints, and Opportunities
Figure 74: Global: Epilepsy Drugs Industry: Value Chain Analysis
Figure 75: Global: Epilepsy Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Epilepsy Drugs Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Epilepsy Drugs Market Forecast: Breakup by Generation Type (in Million USD), 2025-2033
Table 3: Global: Epilepsy Drugs Market Forecast: Breakup by Anti-Epileptics Drugs Type (in Million USD), 2025-2033
Table 4: Global: Epilepsy Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Epilepsy Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Epilepsy Drugs Market: Competitive Structure
Table 7: Global: Epilepsy Drugs Market: Key Players